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ORIGINAL CLINICAL RESEARCH STUDIES
Stenosis or occlusion of the innominate and sub-
clavian arteries may be the cause of cerebral or upper
extremity arterial insufficiency as a result of a rever-
sal blood flow in the ipsilateral vertebral artery dur-
ing upper extremity exercise with blood steal from
cerebral circulation. This clinical picture causes the
so-called “subclavian steal syndrome.”
Occlusions of the innominate and subclavian
arteries often may be asymptomatic.1 Ischemic
symptoms are present when the collateral circulation
to the upper extremity is unable to compensate for a
decrease in blood supply as a result of anatomical
variation or occlusive disease in the carotid, verte-
bral, and circle of Willis arteries.2,3
During the past 40 years, a variety of extra-
anatomic surgical techniques have been advocated to
treat the subclavian steal syndrome and to avoid
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Objective: The outcome of crossover axilloaxillary bypass grafting in patients with steno-
sis or occlusion of the innominate or subclavian arteries was investigated.
Methods: The study was designed as a retrospective clinical study in a university hospital
setting with 61 patients as the basis of the study. Fifty-eight patients (95.1%) had at least
two risk factors or associated medical illnesses for atherosclerosis, and 35 patients
(57.4%) had concomitant carotid artery stenosis that necessitated a staged procedure in
12 patients (19.7%). The patients underwent a total of 63 crossover axilloaxillary bypass
grafting procedures. Demographics, risk factors and associated medical illnesses, preop-
erative symptoms and angiographic data, blood flow inversion in the vertebral artery,
concomitant carotid artery disease, graft shape, caliber and material, and intraoperative
and postoperative complications were studied to assess the specific influence in deter-
mining the outcome.
Results: One postoperative death (1.6%), four early graft thromboses (6.2%), and six
minor complications (9.8%) occurred. The overall mortality and morbidity rates were
1.6% and 16.1%, respectively. During the follow-up period (mean, 97.3 ± 7.9 months),
we observed five graft thromboses (8.3%). Primary and secondary patency rates at 5 and
10 years were 86.5% and 82.8% and 88.1% and 84.3%, respectively. Overall, two patients
(3.3%) had recurrence of upper limb symptoms and none had recurrence of symptoms
in the carotid or vertebrobasilar territory. The 5-year and 10-year symptom-free inter-
val rates were 97.7% and 93.5%, respectively. Nine patients (15%) died of unrelated caus-
es. The 5-year and 10-year survival rates were 93.2% and 67.3%, respectively.
Multivariate analysis showed that no specific variables exerted an influence in the short-
term and long-term results and the outcome.
Conclusion: The optimal outcome of axilloaxillary bypass grafting supports its use as the
most valuable surgical alternative to transthoracic anatomic reconstructions for innom-
inate lesion, long stenosis of the subclavian artery, and short subclavian artery stenosis
associated with ispilateral carotid artery lesions. (J Vasc Surg 1999;29:894-901.)
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transthoracic approaches because of their higher mor-
bidity and mortality rates. Crossover axilloaxillary
bypass grafting, first described by Myers et al4 in 1971
at the Marshfield Clinic (Marshfield, Wis), represents
one of these therapeutic options. Although recent
series have reported optimal short-term and long-
term results, crossover axilloaxillary bypass grafting
has raised several concerns in the literature because of
its theoretical complications, such as thrombosis,
infection, and skin erosion that might be caused by
bypass graft length and subcutaneous position.5-13
The aim of this study was the investigation of
short-term and long-term results of crossover axil-
loaxillary bypass grafting in 61 patients with severe
stenosis or occlusion of the innominate or subclavian
arteries and the definition of its role in the treatment
of this syndrome.
MATERIALS AND METHODS
Between 1973 and 1997, 61 patients underwent
crossover axilloaxillary bypass grafting for neurologic
and upper limb ischemic symptoms at our institution.
Data were retrieved from hospital charts and outpa-
tient logbooks. A total of 63 reconstructions were
performed. Two patients (3.3%) underwent redo
bypass grafting in the early postoperative period.
The study group comprised 43 men and 18
women, and the mean age was 61.5 ± 1.4 years
(median, 64 years; range, 31 to 78 years). Most of
the patients (n = 58; 95.1%) were first seen with at
least two risk factors for atherosclerosis. The risk
factors included tobacco use, diabetes (insulin-
dependent or independent), cardiac disease (prior
myocardial infarction, stable or unstable angina, or
ST segment alteration on electrocardiogram),
hypertension (diastolic pressure, >90 mm Hg),
renal disease (blood urea nitrogen, >50 mg/mL;
creatinine level, >3 mg/mL; creatinine clearance,
<50 mL/min), and pulmonary disease (PO2, <60
mm Hg; PCO2, >50 mm Hg; pulmonary function
tests, <80% of predicted). Table I describes the
demographics, risk factors, and associated medical
illnesses.
All the patients were first examined for upper
limb symptoms. The right upper limb was involved
in 37 cases (60.6%), and the left was involved in 24
cases (39.4%). The symptoms were localized preva-
lently in the upper limb in 38 patients (62.3%), in
the vertebrobasilar territory in 16 patients (26.2%),
and in the carotid territory in 7 patients (11.5%).
The mean decrease of systolic blood pressure in the
affected upper limb was 52.3 ± 1.4 mm Hg. Table II
and Table III show the symptoms of the population.
All the patients underwent evaluation before
surgery with noninvasive vascular laboratory studies
(duplex scanning, Doppler continuous wave scan-
ning, or both) and conventional angiography.
Angiogram results showed occlusion of the innomi-
nate or subclavian arteries in 15 patients (24.6%) and
stenosis in 46 patients (75.4%). The percentage of
stenosis ranged from 65% to 99% (mean, 79% ±
0.6%; median, 81%), and the length of stenosis
ranged from 2 cm to 8 cm (mean, 6.3 ± 0.9 cm;
median, 6 cm). In 15 cases (24.6%), a reversal blood
flow in the vertebral artery was documented at
angiography, and, in 6 cases (9.8%), the vertebral
artery directly originated from the aortic arch.
Thirty-five patients (57.4%) had also a concomitant
Table II. Indications for operation
No. of patients















Amaurosis fugax 4 6.5
Transient ischemic attack 10 16.4
Table I. Demographics
Characteristics
Age (years) 61.5 ± 1.4
Sex (M/F) 43/18
No. of patients Percent
(n = 61)
Risk factors and associated medical 
illnesses




Cardiac disease 21 34.3
Pulmonary disease 18 29.5
Renal disease 9 14.7
Coagulopathy 1 1.6
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carotid artery stenosis—ipsilateral to the innominate
or subclavian artery lesions in 22 cases and con-
tralateral in 13 cases (Table IV).
Surgical technique. General anesthesia was
used in all surgeries. The second portion of the axil-
lary artery was reached through an incision in the
deltoideus-pectoralis major muscle groove. The
minor pectoralis muscle was sectioned in 36 cases
and retracted in 25. The contralateral axillary artery
was reached in a similar manner. A subcutaneous tun-
nel then was performed between the two incisions.
Proximal and distal terminolateral anastomoses
were performed between the axillary artery and a
reversed autogenous saphenous vein (ASV; average
diameter, 5 to 6 mm) in 22 cases, a Dacron graft
(diameter, 8 mm) in 15 cases, or an expanded poly-
tetrafluoroethylene vascular graft (ePTFE; diameter,
8 mm) in 26 cases. In 3 cases (4.9%), the distal anas-
tomosis was performed in the mid portion of the
brachial artery because of the extent of the athero-
sclerotic process. All the grafts had either an italic S
shape (n = 47) or C shape (n = 16) on the basis of
surgeon preference. External supported grafts were
used in 38 cases.
Twelve patients (19.7%), who had a concomitant
ipsilateral severe carotid artery stenosis (>65%), under-
went a staged procedure, with a carotid thromboen-
darterectomy performed from 1 to 3 months before
crossover axilloaxillary bypass graft insertion (mean,
1.2 ± 0.2 months; median, 1 month). Twenty-three
patients (37.7%) with asymptomatic mild carotid
artery stenosis (<40%), ipsilateral to the subclavian
lesion in 11 cases and contralateral in 12, did not
undergo carotid artery stenosis correction.
Postoperative surveillance. The patients were
followed up on a regular basis. Long-term data were
obtained from patient reexamination and noninva-
sive laboratory studies (duplex scanning, Doppler
continuous wave scanning, or both), which were
performed every 4 months for the first year and
every 6 months thereafter. Suspected graft occlusion
was confirmed by means of angiography.
Statistical analysis. The data were entered into a
computer (Z-Station ES/P, Zenith Data Systems
Europe, Nanterre, France) spreadsheet (Microsoft
Excel 97 for Windows 95, Microsoft, Redmond,
Wash). Statistical comparisons were obtained with the
software package SPSS (basic and advanced programs,
version 6.1.3; SPSS, Inc, Chicago, Ill). Patency rates
were calculated on the basis of the number of grafts
and symptom-free intervals, and survival rates were
calculated on the basis of patients (life-table method).
All the values are expressed as the mean ± the standard
error of the mean. The comparisons among groups
were tested with Pearson c 2 test, with Yates correc-
tion for conditional variables, and the comparisons
between curves were performed with the Wilcoxon
rank sum test. Cox proportional hazards regression
model was used to assess the influence of age, sex, risk
factors, associated medical illnesses, preoperative
Table III. Description of peripheral symptoms alone or associated with vertebrobasilar or carotid symptoms
Peripheral symptoms (n = 61)
Sensory Motor Combined
Peripheral symptoms (n = 29) 5 18 6
Peripheral and vertebrobasilar symptoms (n = 20) 5 11 4
Peripheral and carotid symptoms (n = 12) 4 3 5
Table IV. Arch vessels percentage of stenosis with respect to carotid artery disease
Innominate (n = 8) Subclavian (n = 53)
Occlusion Stenosis Occlusion Stenosis
66% to 80% 81% to 99% 66% to 80% 81% to 99%
Carotid artery stenosis
(n = 22)
>65% — — — 4 3 5
<40% — — 2 — 2 6
Innominate artery 3 2 3 — — —
Subclavian artery — — — 8 15 8
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symptoms, angiographic data, vertebral artery blood
flow inversion, concomitant carotid artery disease,
graft shape, graft material, and intraoperative and
postoperative complications in determining long-
term results and outcomes. Significance was taken at
the level of the P value less than .05.
RESULTS
One postoperative death (1.6%), four early graft
thromboses (6.2%), and six minor complications
(9.8%; two wound hematomas, two seromas, one
lymphorrhea, and one superficial wound infection)
occurred. The overall mortality and morbidity rates
were 1.6% and 16.1%, respectively.
The early failures of two ASV vascular grafts
(3.1%) because of their small diameters (4 mm) and
because of sclerosis were treated with the successful
insertion of prosthetic grafts (one ePTFE graft and
one Dacron graft). In the remaining two patients at
high risk (3.1%; American Society of Anesthesiology
class III) with ePTFE bypass graft thrombosis as a
result of technical failure (stenosis and kinking of the
prostheses at the proximal anastomosis), redo bypass
grafting procedures were not performed because of
the refusal of the patients in the absence of cere-
brovascular symptoms. In both cases, the innomi-
nate arteries had short (2 and 2.5 cm) stenotic
lesions (65% and 70%) that were successfully treated
with percutaneous transluminal angioplasty (PTA).
The cumulative patency and survival rates within
hospital stay were 93.5% and 98.4%, respectively.
The mean postoperative length of stay was 5.2 ± 1.3
days (median, 5 days; range, 3 to 8 days).
During the follow-up period (mean, 93.4 ± 1.4
months; median, 84; range, 1 to 248 months), three
patients (5%) with patent grafts were lost to follow-
up at 26, 47, and 58 months. Ten patients (16.7%)
underwent coronary artery revascularization by
means of PTA (seven cases) and stent positioning
(three cases) at a mean follow-up period of 39.8 ±
4.2 months. Ten patients (16.7%) underwent carotid
thromboendarterectomy at a mean follow-up of 23.2
± 14.2 months because of the progression (six cases)
or the development (four cases) of symptomatic ath-
erosclerotic disease (>70%) of the ipsilateral (four
cases) or contralateral (six cases) carotid artery. Five
patients (8.3%) who had undergone operation for
stenosis or occlusion of the subclavian artery had
graft thromboses at 3, 4, 6, 36, and 97 months. In
three cases, we performed thrombectomies of the
reconstructions. This was successful in one case. In
the other two cases, redo bypass grafting was deemed
unnecessary because mild arm claudication developed
in the patients during daily activity, which caused a
significant decrease in systolic blood pressure in the
recipient arms. Neither of the patients presented with
cerebrovascular symptoms: one had a contralateral
carotid thromboendarterectomy a few weeks earlier
than the bypass graft failure. In the remaining two
patients, who retired from bricklayer and house
painter jobs during the follow-up period, the occlu-
sions of the reconstructions were asymptomatic.
Fig 1. Cumulative primary and secondary patency rates tabulated according to life-table
method (numbers represent grafts at risk).
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The cumulative primary and secondary patency
rates at 5 years and 10 years were 86.5% and 82.8%
and 88.1% and 84.3%, respectively (Fig 1). The symp-
tom-free interval rates were 97.7% at 5 years and
93.5% at 10 years. We never observed progression of
atherosclerosis at the donor arm. Overall, two patients
(3.3%) had arm claudication develop because of the
occlusion of the reconstruction, and the remaining
patients with patent grafts had no symptom recur-
rence. Hemispheric transient ischemic symptoms that
necessitated carotid thromboendarterectomy during
the follow-up period were not included in the analy-
sis of the symptom-free interval.
Ten patients (16.7%) died at 4, 11, 24, 92, 93,
107, 111, 131, 176, and 184 months. During the
follow-up period, no patients died for related causes.
The deaths were caused by cardiac diseases in six
cases and by cancer in four cases. Five-year and 10-
year cumulative survival rates were 93.2% and
67.3%, respectively.
Univariate analysis and Cox proportional hazards
regression method showed that age, sex, risk factors
and associated medical illnesses, preoperative symp-
toms and angiographic data, vertebral artery blood
flow inversion, concomitant carotid artery disease,
graft shape, caliber, and material, external support, and
intraoperative and postoperative complications did not
exert any specific influence in determining long-term
survival and patency rates. In Fig 2, it is shown that the
type of material used for reconstruction did not influ-
ence short-term and long-term patency rates (P = NS).
Patient compliance and cosmetic acceptance of
this procedure was overall excellent or good in all
the patients. None of the patients reported distur-
bance from prominent graft pulsation in the sternal
area. No correlation was found between ASV or
unreinforced prosthetic bypass graft thromboses and
the sleeping position.
DISCUSSION
Proximal subclavian artery occlusive disease is
uncommon (1% and 3% in a large series of vascular
patients) and, in most cases, symptomless.14-16 Even
if a reversed blood flow in the ipsilateral vertebral
artery is documented, symptoms of vertebrobasilar
insufficiency are rarely present, which suggests that
subclavian steal syndrome is generally a benign
hemodynamic phenomenon15-18 because of the rich
collateral supply.19,20
A reduced efficiency of collateral circulation,
because of other hemodynamically significant extra-
cranial lesions or anatomic anomalies, causes cere-
bral and peripheral symptoms.17,21-23 When these
symptoms occur, a careful search for other extracra-
nial cerebral vascular diseases and their correction is
recommended before subclavian revascularization.24
Conversely, patients with isolated subclavian stenosis
or occlusion are usually at low risk for stroke and
most of them have symptom remission within 2
years.14,15,22 A nonsurgical approach has been advo-
cated for these patients unless transient ischemic
attacks or severe upper limb ischemic symptoms
Fig 2. Primary patency rates of different types of graft materials used for reconstruction, tab-
ulated according to the life-table method (numbers represent grafts at risk).
occur.25,26 Patients who require surgical treatment are
therefore few. Because of the concomitant involve-
ment of several supra-aortic vessels, timing and surgi-
cal methods are still under debate.
During the past decades, several approaches to
treatment have been proposed, but none of the
approaches has shown any real benefit over the oth-
ers. Intrathoracic revascularization procedures have
high mortality rates (6% to 20%).27,29 Recent devel-
opments in operative and anesthetic techniques and
in postoperative care have significantly reduced the
risk of such procedures at only some institutions.30,31
PTA had a great popularity because of the low
complication rate,32-34 but it can be used only when
subclavian artery stenosis is short (<4 cm in length).
PTA also has a high rate of recurrence (patency rate
from 80% at 2 years to 54% at 5 years), which often
necessitates repeated dilatations during the follow-
up period.34-37
Stenting of the subclavian artery has attracted
considerable interest, even for short occlusive lesions.
However, further evaluations in larger groups of
patients with longer follow-up periods are needed to
confirm the intriguing patency rate of 80% reported
in a 2-year follow-up period.38,39
Carotid-subclavian bypass grafting procedures
have extremely low mortality rates (1.9%) and optimal
primary patency rates (95%).40-42 However, several
authors43-47 have criticized this reconstruction and
proposed the subclavian-carotid transposition. Sub-
clavian-carotid transposition offers some advantages
over carotid-subclavian bypass grafting, such as the
avoidance of prosthetic materials, which thus annuls
the risk of infection (0.0% vs 1.5%),41 and the
decrease of myointimal hyperplasia formation because
of the similar vessel diameters.43-46 However, the sub-
clavian artery cannot always be transposed because it
is difficult to reach in the superior mediastinum and
the operation may be complicated with a temporary
Horner’s syndrome, hoarseness, and bleeding, which
would require reoperation.9,44,48 Both reconstruc-
tions cannot be used with innominate artery lesions
and with the involved subclavian artery segment
exceeding 6 to 7 cm in length. Furthermore, a major
problem for these operations is the simultaneous and
frequent (32%)49,50 presence of ipsilateral carotid
artery stenosis.
Axilloaxillary bypass grafting is the less frequently
used procedure because it has raised a number of crit-
icisms for its length and subcutaneous course, which
might cause thrombosis, for cutaneous skin erosion,
and for the technical management of an eventual and
subsequent coronary artery disease. Our results,
which are confirmed by those reported by others,12,51
have shown that axilloaxillary bypass grafting is easily
performed, that postoperative mortality (1.6%) and
morbidity (16.1%) rates are low, and that 10-year
patency rates (84.3%) are excellent. In this study,
which encompasses the widest series with the longest
follow-up period (mean follow-up period, >8 years),
only two patients were seen with peripheral symptom
recurrence and the complications related to the sub-
cutaneous course and length of this reconstruction
were never observed. Stipa et al,12 in the widest liter-
ature review on axilloaxillary bypass grafting (237
bypass grafting procedures performed between 1973
and 1985), showed that these complications were
extremely rare with five skin erosions (2.1%) and one
infection (0.4%). This review showed that the con-
cerns expressed for axilloaxillary bypass grafting are
baseless. The treatment of coronary artery disease,
developed during the follow-up period, should con-
sist of PTA and stent positioning, as in our series, or
of the adoption of minimally invasive coronary artery
bypass graft surgery. Furthermore, we recommend a
careful search for coronary artery disease and its treat-
ment before the construction of an axilloaxillary
bypass graft.
Mandatory indication for axilloaxillary bypass
grafting is stenosis or occlusion of the subclavian
artery longer than 6 to 7 cm. This procedure repre-
sents the extra-anatomic alternative to a transtho-
racic reconstruction in the presence of innominate
artery disease, and it is the operation of choice when
concomitant atherosclerotic lesions in the supra-aor-
tic vessels are present. Although the risk of intraop-
erative and postoperative stroke is more theoretical
than real, the progression of atherosclerosis and the
occurrence of restenosis in a carotid artery that has
undergone thromboendarterectomy could limit
long-term patency rates of the other reconstruc-
tions. In a previous study,9 we demonstrated that
carotid-subclavian bypass grafting had lower patency
rates than axilloaxillary bypass grafting (40.8% vs
100% at 10-year follow-up interval) when a con-
comitant ipsilateral carotid lesion was present with a
significant higher postoperative and long-term inci-
dence rate of minor and major cerebral events.
Several authors42,46 have not observed these compli-
cations and recommend the use of carotid-subcla-
vian reconstruction because of their optimal results.
In our series, the concomitant or subsequent
involvement of the carotid arteries, ipsilaterally or
contralaterally to the subclavian lesions, was 57.4%,
which thus testifies that our patients had more
advanced and widespread atherosclerotic disease. On
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the other hand, the data from large recent series of
patients who underwent treatment with subclavian-
carotid transposition or bypass grafting have shown
a lower incidence rate of carotid involvement. Vitti
et al42 have observed 36 of 140 patients (25.7%)
with ipsilateral or contralateral carotid artery steno-
sis, and Edwards et al46 have treated 10 carotid
stenoses of 178 subclavian-carotid transpositions in
175 patients. If we consider the multilevel vessel
involvement reported in this series and in other
series dealing with axilloaxillary bypass grafts,51
these data are surprising and the optimal long-term
results of carotid-subclavian reconstructions should
be tempered by the fact that patients with isolated
subclavian stenosis or occlusion usually have sponta-
neous symptom remission in a few years.
For these reasons, in the presence of simultaneous
carotid and subclavian artery stenoses, we treat the
carotid artery stenosis first. This is essential for cere-
brovascular revascularization. The correction of sub-
clavian artery stenosis is used only if arm symptoms
persist. In these cases, the contralateral axillary artery
represents the optimal donor artery because, among
the supra-aortic trunks, it is the least likely to develop
stenotic lesions. This approach reduces the risk of graft
thrombosis and the incidence rate of complications
related to the use of the carotid artery as source of
inflow. Edwards et al46 have described three patients
with recurrence of symptoms because of the develop-
ment of carotid artery stenosis proximal to the subcla-
vian-carotid transposition, and Brandl et al52 have
reported two transient ischemic attacks (one in the
vertebrobasilar territory) after a combined carotid
endarterectomy and a subclavian-carotid transposition.
In conclusion, crossover axilloaxillary bypass
grafting can be safely used in patients in whom other
extra-anatomic surgical approaches are not practica-
ble because of the characteristics and site of the
lesions. This procedure permits optimal long-term
patency rates and symptom-free intervals that are
similar to those obtained with carotid-subclavian
bypass grafting or subclavian-carotid transposition.
Crossover axilloaxillary bypass grafts should also be
selected in patients with concomitant ipsilateral
carotid artery stenosis when symptoms persist after
its correction to avoid the use of a diseased artery
that may undergo restenosis that limits the patency
rates of this reconstruction.
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